Monsta Mash/ – At the beginning of 2024, Forbes released the list of the top 17 crypto billionaires. Among them was Tim Draper whose source of wealth was investing in Bitcoin early; in 2014.
Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...
Madrigal Pharma has become the first drugmaker to claim FDA approval for a drug to treat metabolic dysfunction-associated steatohepatitis (MASH), an elusive target that has seen many other ...